198 related articles for article (PubMed ID: 23828855)
1. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study.
Bogazzi F; Colao A; Rossi G; Lombardi M; Urbani C; Sardella C; Iannelli A; Scattina I; Manetti L; Del Sarto S; Pivonello R; Grasso LF; Lupi I; Auriemma RS; Lombardi G; Martino E
Eur J Endocrinol; 2013 Sep; 169(3):367-76. PubMed ID: 23828855
[TBL] [Abstract][Full Text] [Related]
2. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).
Colao A; Vandeva S; Pivonello R; Grasso LF; Nachev E; Auriemma RS; Kalinov K; Zacharieva S
Eur J Endocrinol; 2014 Aug; 171(2):263-73. PubMed ID: 24878680
[TBL] [Abstract][Full Text] [Related]
3. Postoperative use of somatostatin analogs and mortality in patients with acromegaly.
Postma MR; Wolters TLC; van den Berg G; van Herwaarden AE; Muller Kobold AC; Sluiter WJ; Wagenmakers MA; van den Bergh ACM; Wolffenbuttel BHR; Hermus ARMM; Netea-Maier RT; van Beek AP
Eur J Endocrinol; 2019 Jan; 180(1):1-9. PubMed ID: 30400068
[TBL] [Abstract][Full Text] [Related]
4. Effects of medical therapies for acromegaly on glucose metabolism.
Urbani C; Sardella C; Calevro A; Rossi G; Scattina I; Lombardi M; Lupi I; Manetti L; Martino E; Bogazzi F
Eur J Endocrinol; 2013 Jul; 169(1):99-108. PubMed ID: 23660641
[TBL] [Abstract][Full Text] [Related]
5. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center.
Bacigaluppi S; Gatto F; Anania P; Bragazzi NL; Rossi DC; Benvegnu G; Nazzari E; Spaziante R; Giusti M; Ferone D; Zona G
Endocrine; 2016 Mar; 51(3):524-33. PubMed ID: 25982150
[TBL] [Abstract][Full Text] [Related]
6. [Outcome of somatostatin analogue treatment in acromegaly].
Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
[TBL] [Abstract][Full Text] [Related]
7. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
Duan L; Zhu H; Xing B; Gu F
BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
[TBL] [Abstract][Full Text] [Related]
8. Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy.
Colao A; Pivonello R; Galderisi M; Cappabianca P; Auriemma RS; Galdiero M; Cavallo LM; Esposito F; Lombardi G
J Clin Endocrinol Metab; 2008 Jul; 93(7):2639-46. PubMed ID: 18445662
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure.
Puig-Domingo M; Resmini E; Gomez-Anson B; Nicolau J; Mora M; Palomera E; Martí C; Halperin I; Webb SM
J Clin Endocrinol Metab; 2010 Nov; 95(11):4973-8. PubMed ID: 20739382
[TBL] [Abstract][Full Text] [Related]
10. Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.
Sardella C; Cappellani D; Urbani C; Manetti L; Marconcini G; Tomisti L; Lupi I; Rossi G; Scattina I; Lombardi M; Di Bello V; Marcocci C; Martino E; Bogazzi F
Eur J Endocrinol; 2016 Nov; 175(5):443-53. PubMed ID: 27528501
[TBL] [Abstract][Full Text] [Related]
11. Cardiac risk in patients with treatment naïve, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general population.
Berg C; Petersenn S; Walensi M; Möhlenkamp S; Bauer M; Lehmann N; Roggenbuck U; Moebus S; Broecker-Preuss M; Sandalcioglu IE; Stolke D; Sure U; Joeckel KH; Erbel R; Führer D; Mann K;
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):125-32. PubMed ID: 23338744
[TBL] [Abstract][Full Text] [Related]
12. Results of surgical and somatostatin analog therapies and their combination in acromegaly: a retrospective analysis of the German Acromegaly Register.
Petersenn S; Buchfelder M; Reincke M; Strasburger CM; Franz H; Lohmann R; Quabbe HJ; Plöckinger U;
Eur J Endocrinol; 2008 Nov; 159(5):525-32. PubMed ID: 18755874
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly.
Zawada NB; Kunert-Radek J; Pawlikowski M; Pisarek H; Radek M
Endokrynol Pol; 2016; 67(3):292-8. PubMed ID: 27345147
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients.
Cappellani D; Urbani C; Sardella C; Scattina I; Marconcini G; Lupi I; Manetti L; Marcocci C; Bogazzi F
Endocrinol Diabetes Metab; 2019 Jan; 2(1):e00033. PubMed ID: 30815570
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.
Beauregard C; Truong U; Hardy J; Serri O
Clin Endocrinol (Oxf); 2003 Jan; 58(1):86-91. PubMed ID: 12519417
[TBL] [Abstract][Full Text] [Related]
16. Preoperative somatostatin analogs treatment in acromegalic patients with macroadenomas. A meta-analysis.
Zhang L; Wu X; Yan Y; Qian J; Lu Y; Luo C
Brain Dev; 2015 Feb; 37(2):181-90. PubMed ID: 24815226
[TBL] [Abstract][Full Text] [Related]
17. Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.
Sherlock M; Fernandez-Rodriguez E; Alonso AA; Reulen RC; Ayuk J; Clayton RN; Holder G; Sheppard MC; Bates A; Stewart PM
J Clin Endocrinol Metab; 2009 Apr; 94(4):1255-63. PubMed ID: 19158203
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of acromegaly in Spain].
Sesmilo G
Endocrinol Nutr; 2013 Oct; 60(8):470-4. PubMed ID: 23246411
[TBL] [Abstract][Full Text] [Related]
19. The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes.
Portocarrero-Ortiz LA; Vergara-Lopez A; Vidrio-Velazquez M; Uribe-Diaz AM; García-Dominguez A; Reza-Albarrán AA; Cuevas-Ramos D; Melgar V; Talavera J; Rivera-Hernandez AJ; Valencia-Méndez CV; Mercado M;
J Clin Endocrinol Metab; 2016 Nov; 101(11):3997-4004. PubMed ID: 27428551
[TBL] [Abstract][Full Text] [Related]
20. Mortality in acromegaly: a metaanalysis.
Dekkers OM; Biermasz NR; Pereira AM; Romijn JA; Vandenbroucke JP
J Clin Endocrinol Metab; 2008 Jan; 93(1):61-7. PubMed ID: 17971431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
